Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer

dc.date.accessioned	2021-06-08T09:11:30Z
dc.date.available	2021-06-08T09:11:30Z
dc.date.issued	2020
dc.identifier.issn	1018-4813
dc.identifier.uri	https://hdl.handle.net/20.500.12619/95965
dc.description	Bu yayının lisans anlaşması koşulları tam metin açık erişimine izin vermemektedir.
dc.language	English
dc.language.iso	eng
dc.publisher	SPRINGERNATURE
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer
dc.type	Meeting Abstract
dc.identifier.volume	28
dc.identifier.startpage	697
dc.identifier.endpage	698
dc.relation.journal	EUROPEAN JOURNAL OF HUMAN GENETICS
dc.identifier.issue	SUPPL 1
dc.identifier.eissn	1476-5438
dc.contributor.author	Eskiler, G. Guney
dc.contributor.author	Ozman, Z.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı